Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | E7386 |
Trade Name | |
Synonyms | E 7386|E-7386 |
Drug Descriptions |
E7386 inhibits the interaction between CBP and beta-catenin, resulting in decreased Wnt pathway signaling and potentially leading to alteration of the tumor microenvironment and decreased tumor growth (PMID: 33408116). |
DrugClasses | WNT Inhibitor 16 |
CAS Registry Number | NA |
NCIT ID | C153376 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
E7386 | E7386 | 0 | 1 |
E7386 + Lenvatinib | E7386 Lenvatinib | 0 | 1 |
E7386 + Pembrolizumab | E7386 Pembrolizumab | 0 | 1 |